Pages that link to "Q39530341"

The following pages link to Tyrosine phosphorylation of transcriptional coactivator WW‐domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway (Q39530341):

Displaying 29 items.

• estrogen receptor 1 (Q5401858) (← links)
• WW domain binding protein 2 (Q21174629) (← links)
• TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex (Q27340453) (← links)
• Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearing. (Q30386999) (← links)
• Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cells (Q34245749) (← links)
• FH535 inhibited migration and growth of breast cancer cells (Q34415881) (← links)
• Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer (Q34644776) (← links)
• Biophysical Analysis of Binding of WW Domains of the YAP2 Transcriptional Regulator to PPXY Motifs within WBP1 and WBP2 Adaptors (Q35534580) (← links)
• Elevated Expression of the Testis-specific Gene WBP2NL in Breast Cancer (Q35811147) (← links)
• p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch (Q36183728) (← links)
• Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells (Q36347787) (← links)
• The bone-sparing effects of estrogen and WNT16 are independent of each other (Q36354870) (← links)
• The hippo-yes association protein pathway in liver cancer (Q37108727) (← links)
• The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway (Q38015671) (← links)
• WBP2 modulates G1/S transition in ER  breast cancer cells and is a direct target of miR-206. (Q38708424) (← links)
• The Evaluation of WBP2NL-Related Genes Expression in Breast Cancer (Q38938421) (← links)
• Expression analysis of PAWP during mouse embryonic stem cell-based spermatogenesis in vitro (Q39038023) (← links)
• Organizational metrics of interchromatin speckle factor domains: integrative classifier for stem cell adhesion & lineage signaling (Q39416729) (← links)
• WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer (Q39445786) (← links)
• Estrogen enhances activity of Wnt signaling during osteogenesis by inducing Fhl1 expression. (Q42830464) (← links)
• WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma. (Q52678274) (← links)
• Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches. (Q64928619) (← links)
• An in silico proteomics screen to predict and prioritize protein-protein interactions dependent on post-translationally modified motifs (Q88989882) (← links)
• Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription (Q89224658) (← links)
• Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases (Q90440580) (← links)
• Genetic and molecular biology of breast cancer among Iranian patients (Q91735135) (← links)
• The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway (Q93159737) (← links)
• The emerging roles of WBP2 oncogene in human cancers (Q94562813) (← links)
• Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer (Q98611509) (← links)